Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Applied Informatics Decision Support Tool for Mortality Predictions in Patients With Cancer.

Bertsimas D, Dunn J, Pawlowski C, Silberholz J, Weinstein A, Zhuo YD, Chen E, Elfiky AA.

JCO Clin Cancer Inform. 2018 Dec;2:1-11. doi: 10.1200/CCI.18.00003.

2.

Development and Application of a Machine Learning Approach to Assess Short-term Mortality Risk Among Patients With Cancer Starting Chemotherapy.

Elfiky AA, Pany MJ, Parikh RB, Obermeyer Z.

JAMA Netw Open. 2018 Jul 6;1(3):e180926. doi: 10.1001/jamanetworkopen.2018.0926.

3.

Accreditation Standard Guideline Initiative for Tai Chi and Qigong Instructors and Training Institutions.

Oh B, Yeung A, Klein P, Larkey L, Ee C, Zaslawski C, Knobf T, Payne P, Stener-Victorin E, Lee R, Choi W, Chun M, Bonucci M, Lang HD, Pavlakis N, Boyle F, Clarke S, Back M, Yang P, Wei Y, Guo X, Weng CD, Irwin MR, Elfiky AA, Rosenthal D.

Medicines (Basel). 2018 Jun 8;5(2). pii: E51. doi: 10.3390/medicines5020051.

4.

Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial.

Antonarakis ES, Kibel AS, Yu EY, Karsh LI, Elfiky A, Shore ND, Vogelzang NJ, Corman JM, Millard FE, Maher JC, Chang NN, DeVries T, Sheikh NA, Drake CG; STAND Investigators.

Clin Cancer Res. 2017 May 15;23(10):2451-2459. doi: 10.1158/1078-0432.CCR-16-1780. Epub 2016 Nov 10.

5.

Oxidative stress in prostate cancer patients: A systematic review of case control studies.

Oh B, Figtree G, Costa D, Eade T, Hruby G, Lim S, Elfiky A, Martine N, Rosenthal D, Clarke S, Back M.

Prostate Int. 2016 Sep;4(3):71-87. doi: 10.1016/j.prnil.2016.05.002. Epub 2016 May 24. Review.

6.

Assessment and management of advanced adrenocortical carcinoma using a precision oncology care model.

Elfiky AA, Krishnan Nair HK.

Discov Med. 2016 Jan;21(113):49-56. Review.

7.

Duration of Androgen Deprivation Therapy for High-Risk Prostate Cancer: Application of Randomized Trial Data in a Tertiary Referral Cancer Center.

Muralidhar V, Regan MM, Werner L, Nakabayashi M, Evan CP, Bellmunt J, Choueiri TK, Elfiky AA, Harshman LC, McKay RR, Pomerantz MM, Sweeney CJ, Taplin ME, Kantoff PW, Nguyen PL.

Clin Genitourin Cancer. 2016 Aug;14(4):e299-305. doi: 10.1016/j.clgc.2015.12.008. Epub 2015 Dec 17.

PMID:
26778006
8.

Adrenocortical Carcinoma: A Clinician's Perspective.

Elfiky A.

Surg Pathol Clin. 2015 Dec;8(4):751-4. doi: 10.1016/j.path.2015.07.002. Review.

PMID:
26612225
9.

Practice innovation: the need for nimble data platforms to implement precision oncology care.

Elfiky A, Zhang D, Krishnan Nair HK.

Discov Med. 2015 Jul-Aug;20(108):27-32. Review.

10.

The effect of technology-based interventions on pain, depression, and quality of life in patients with cancer: a systematic review of randomized controlled trials.

Agboola SO, Ju W, Elfiky A, Kvedar JC, Jethwani K.

J Med Internet Res. 2015 Mar 13;17(3):e65. doi: 10.2196/jmir.4009. Review.

11.

Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study.

Fay AP, Signoretti S, Callea M, Telό GH, McKay RR, Song J, Carvo I, Lampron ME, Kaymakcalan MD, Poli-de-Figueiredo CE, Bellmunt J, Hodi FS, Freeman GJ, Elfiky A, Choueiri TK.

J Immunother Cancer. 2015 Feb 17;3:3. doi: 10.1186/s40425-015-0047-3. eCollection 2015.

12.

Improving outcomes in cancer patients on oral anti-cancer medications using a novel mobile phone-based intervention: study design of a randomized controlled trial.

Agboola S, Flanagan C, Searl M, Elfiky A, Kvedar J, Jethwani K.

JMIR Res Protoc. 2014 Dec 23;3(4):e79. doi: 10.2196/resprot.4041.

13.

A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancer.

Courtney KD, Manola JB, Elfiky AA, Ross R, Oh WK, Yap JT, Van den Abbeele AD, Ryan CW, Beer TM, Loda M, Priolo C, Kantoff P, Taplin ME.

Clin Genitourin Cancer. 2015 Apr;13(2):113-23. doi: 10.1016/j.clgc.2014.08.007. Epub 2014 Oct 22.

14.

Income inequality and treatment of African American men with high-risk prostate cancer.

Ziehr DR, Mahal BA, Aizer AA, Hyatt AS, Beard CJ, D Amico AV, Choueiri TK, Elfiky A, Lathan CS, Martin NE, Sweeney CJ, Trinh QD, Nguyen PL.

Urol Oncol. 2015 Jan;33(1):18.e7-18.e13. doi: 10.1016/j.urolonc.2014.09.005. Epub 2014 Oct 11.

PMID:
25306287
15.

Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study.

Smith MR, Sweeney CJ, Corn PG, Rathkopf DE, Smith DC, Hussain M, George DJ, Higano CS, Harzstark AL, Sartor AO, Vogelzang NJ, Gordon MS, de Bono JS, Haas NB, Logothetis CJ, Elfiky A, Scheffold C, Laird AD, Schimmoller F, Basch EM, Scher HI.

J Clin Oncol. 2014 Oct 20;32(30):3391-9. doi: 10.1200/JCO.2013.54.5954. Epub 2014 Sep 15.

16.

Adrenocortical carcinoma: the management of metastatic disease.

Fay AP, Elfiky A, Teló GH, McKay RR, Kaymakcalan M, Nguyen PL, Vaidya A, Ruan DT, Bellmunt J, Choueiri TK.

Crit Rev Oncol Hematol. 2014 Nov;92(2):123-32. doi: 10.1016/j.critrevonc.2014.05.009. Epub 2014 Jun 4. Review.

17.

Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancer.

Mahal BA, Ziehr DR, Aizer AA, Hyatt AS, Lago-Hernandez C, Choueiri TK, Elfiky AA, Hu JC, Sweeney CJ, Beard CJ, D'Amico AV, Martin NE, Kim SP, Lathan CS, Trinh QD, Nguyen PL.

J Geriatr Oncol. 2014 Oct 1;5(4):352-8. doi: 10.1016/j.jgo.2014.05.001. Epub 2014 May 23.

PMID:
24862107
18.

Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib.

Wagle N, Grabiner BC, Van Allen EM, Hodis E, Jacobus S, Supko JG, Stewart M, Choueiri TK, Gandhi L, Cleary JM, Elfiky AA, Taplin ME, Stack EC, Signoretti S, Loda M, Shapiro GI, Sabatini DM, Lander ES, Gabriel SB, Kantoff PW, Garraway LA, Rosenberg JE.

Cancer Discov. 2014 May;4(5):546-53. doi: 10.1158/2159-8290.CD-13-0353. Epub 2014 Mar 13.

19.

Using FastTrack to Implement an Academic Medical Center and Community Health Center Collaborative for Cancer Care Delivery.

Waldman LT, Bean W, Levine AL, Cohen-Bearak A, Phelps FA, Svoboda L, Freedman R, Elfiky A, Berlin S, Abel GA, Deutsch C, Lathan CS.

Healthc (Amst). 2013 Dec;1(3-4):130-135. No abstract available.

20.

The role of Src in colon cancer and its therapeutic implications.

Chen J, Elfiky A, Han M, Chen C, Saif MW.

Clin Colorectal Cancer. 2014 Mar;13(1):5-13. doi: 10.1016/j.clcc.2013.10.003. Epub 2013 Nov 13. Review.

PMID:
24361441

Supplemental Content

Loading ...
Support Center